[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Supernus Pharm (SUPN)

Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,990,801
  • Shares Outstanding, K 58,040
  • Annual Sales, $ 718,950 K
  • Annual Income, $ -38,550 K
  • EBIT $ 27 M
  • EBITDA $ 117 M
  • 60-Month Beta 0.57
  • Price/Sales 4.22
  • Price/Cash Flow 13.85
  • Price/Book 2.82

Options Overview Details

View History
  • Implied Volatility 39.21% (-4.20%)
  • Historical Volatility 31.49%
  • IV Percentile 18%
  • IV Rank 35.80%
  • IV High 66.99% on 09/26/25
  • IV Low 23.73% on 06/11/25
  • Expected Move (DTE 5) 1.87 (3.63%)
  • Put/Call Vol Ratio 3.00
  • Today's Volume 8
  • Volume Avg (30-Day) 28
  • Put/Call OI Ratio 2.64
  • Today's Open Interest 1,813
  • Open Int (30-Day) 1,850
  • Expected Range 49.66 to 53.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.34
  • Number of Estimates 1
  • High Estimate $0.34
  • Low Estimate $0.34
  • Prior Year $0.78
  • Growth Rate Est. (year over year) -56.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
46.87 +9.94%
on 05/06/26
52.96 -2.70%
on 05/06/26
-0.08 (-0.16%)
since 04/08/26
3-Month
46.83 +10.04%
on 03/20/26
59.68 -13.66%
on 02/25/26
-0.12 (-0.23%)
since 02/06/26
52-Week
30.83 +67.14%
on 06/25/25
59.68 -13.66%
on 02/25/26
+19.99 (+63.38%)
since 05/08/25

Most Recent Stories

More News
Why Supernus Pharmaceuticals (SUPN) Stock Is Up Today

Why Supernus Pharmaceuticals (SUPN) Stock Is Up Today

SUPN : 51.53 (-1.43%)
Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference

ROCKVILLE, Md., May 06, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central...

SUPN : 51.53 (-1.43%)
SUPN Q1 Deep Dive: Growth Products Drive Revenue Upside, Guidance Highlights Execution Challenges

SUPN Q1 Deep Dive: Growth Products Drive Revenue Upside, Guidance Highlights Execution Challenges

SUPN : 51.53 (-1.43%)
1 Healthcare Stock with Competitive Advantages and 2 Facing Challenges

1 Healthcare Stock with Competitive Advantages and 2 Facing Challenges

SUPN : 51.53 (-1.43%)
ELV : 378.07 (+1.38%)
BMY : 56.16 (-0.16%)
Supernus: Q1 Earnings Snapshot

Supernus: Q1 Earnings Snapshot

SUPN : 51.53 (-1.43%)
Supernus Pharmaceuticals’s (NASDAQ:SUPN) Q1 CY2026 Sales Beat Estimates

Supernus Pharmaceuticals’s (NASDAQ:SUPN) Q1 CY2026 Sales Beat Estimates

SUPN : 51.53 (-1.43%)
Supernus Announces First Quarter 2026 Financial Results

Total revenues were $207.7 million in the first quarter 2026, a 39% increase compared to same period last year. Combined revenues of the Company's four growth products increased to $149.1 million in...

SUPN : 51.53 (-1.43%)
Supernus's CNS Portfolio Expansion Masking the Real Question About Core ADHD Economics

Barchart Research What to Expect from SUPN Earnings SUPN Generated May 4, 2026 Current Price $48.63 EPS Estimate $$0.14 Consensus Rating Moderate Buy Average Move 8.29% Supernus's CNS Portfolio Expansion...

SUPN : 51.53 (-1.43%)
Supernus Pharmaceuticals Earnings: What To Look For From SUPN

Supernus Pharmaceuticals Earnings: What To Look For From SUPN

SUPN : 51.53 (-1.43%)
Branded Pharmaceuticals Stocks Q4 Results: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN)

Branded Pharmaceuticals Stocks Q4 Results: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN)

SUPN : 51.53 (-1.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit...

See More

Key Turning Points

3rd Resistance Point 54.86
2nd Resistance Point 53.73
1st Resistance Point 52.63
Last Price 51.53
1st Support Level 50.39
2nd Support Level 49.26
3rd Support Level 48.16

See More

52-Week High 59.68
Last Price 51.53
Fibonacci 61.8% 48.66
Fibonacci 50% 45.26
Fibonacci 38.2% 41.85
52-Week Low 30.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.